SLS:NASDAQ
Sellas Life Sciences Group Inc
$13.70
arrow_downward
-3.25%(-0.46) 1D
$13.73
arrow_upward
+0.22% (+0.030)bedtimeAfter hours
Closed: Sep 3, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLS...
Open
$14.06
High
$14.54
Low
$13.55
Mkt. cap
2.77B
Avg. vol.
6.89M
Volume
5.78M
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.22
Beta
2.52
Shares outstanding
201.95M
No. of employees
13
Open
$14.06
High
$14.54
Low
$13.55
Mkt. cap
2.77B
Avg. vol.
6.89M
Volume
5.78M
52-wk high
$15.88
52-wk low
$1.39
EPS
-$0.22
Beta
2.52
Shares outstanding
201.95M
No. of employees
13
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
SELLAS Life Sciences Group (SLS) Lands 3 AACR Abstracts For SLS009 Pancreatic Cancer Data
Yahoo Finance
·
1 day ago
SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer
Barchart.com
·
2 days ago
Why Analysts Think Sellas Life Sciences Stock Can Gain 150% From Here
About Sellas Life Sciences Group Inc
CEOAngelos M. Stergiou
Employees13
Founded2006
Headquarters-
SectorBiotechnology
Websitesellaslifesciences.com